Accessibility Menu
ViaDerma logo

ViaDerma

(OTC) VDRM

Current Price$0.00
Market Cap$370.10K
Since IPO (2009)-100%
5 Year-99%
1 Year+0%
1 Month-25%

ViaDerma Financials at a Glance

Market Cap

$370.10K

Revenue (TTM)

$600.88K

Net Income (TTM)

-$227.34K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.52 (Low)

Price

$0.00

Volume

312,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Oct 1, 2025

VDRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ViaDerma

Industry

Pharmaceuticals

CEO

Chris Ayo Otiko, PhD

Headquarters

Marina del Rey, CA 90292, US

VDRM Financials

Key Financial Metrics (TTM)

Gross Margin

99.97%

Operating Margin

30.85%

Net Income Margin

0.68%

Return on Equity

-0.48%

Return on Capital

41.53%

Return on Assets

0.32%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$370.10K

Shares Outstanding

1.23B

Volume

312.50K

Avg. Volume

87.76K

Financials (TTM)

Gross Profit

$600.68K

Operating Income

-$145.83K

EBITDA

-$145.64K

Operating Cash Flow

-$506.84K

Capital Expenditure

$0.00

Free Cash Flow

-$506.84K

Cash & ST Invst.

$1.49M

Total Debt

$1.86M

ViaDerma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$150.19K

-0.0%

Gross Profit

$150.14K

-0.0%

Gross Margin

99.97%

N/A

Market Cap

$370.10K

N/A

Market Cap/Employee

$4.93K

N/A

Employees

75

N/A

Net Income

-$321.55K

-906.1%

EBITDA

-$294.40K

-606.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$1.49M

+15005.3%

Total Debt

$1.86M

+476.9%

Accounts Receivable

$4.00K

-99.6%

Inventory

$2.25M

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.86M

+476.9%

Return on Assets

0.32%

N/A

Return on Invested Capital

1.50%

N/A

Free Cash Flow

-$874.84K

-2916033.3%

Operating Cash Flow

-$874.84K

-2916040.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AOXGAoxing Pharmaceutical Company, Inc.
$0.00+0.00%
GPFTGrapefruit USA, Inc.
$0.00-33.33%
SFLMSFLMaven Corp.
$0.00+0.00%
GSACGelStat Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.35-0.05%

Questions About VDRM

What is the current price of ViaDerma?

ViaDerma is trading at $0.00 per share.

What is the 52-week range for ViaDerma?

Over the past 52 weeks, ViaDerma has traded between $0.00 and $0.01.

How much debt does ViaDerma have?

As of the most recent reporting period, ViaDerma reported total debt of $5.91M.

How much cash does ViaDerma have on hand?

ViaDerma reported $11.86K in cash and cash equivalents in its most recent financial results.

What is ViaDerma’s dividend yield?

ViaDerma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.